aluates Reports

$ 0.0

Automative

Rotavirus Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-7F2159

Global Rotavirus Vaccines Market Insights and Forecast to 2028

BUY CHAPTERS

Rotavirus Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-7F2159

Report

September 2024

Pages:100

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bharat Biotech

Merck& Co. Inc

GlaxoSmithKline PLC

Lanzhou Institute of Biological

Bharat Biotech International Limited

Rotavirus Vaccines - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Rotavirus Vaccines - Market

Rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children. The vaccines prevent 15–34% of severe diarrhea in the developing world and 37–96% of severe diarrhea in the developed world. The vaccines decrease the risk of death among young children due to diarrhea. Immunizing babies decreases rates of disease among older people and those who have not been immunized.

The World Health Organization (WHO) recommends that rotavirus vaccine be included in national routine vaccinations programs, especially in areas where the disease is common. This should be done along with promoting breastfeeding, handwashing, clean water and good sanitation. It is given by mouth and requires two or three doses. It should be given starting around six weeks of age.

The vaccines are safe. This includes their use in people with HIV/AIDS. An earlier vaccine that is no longer used was linked to intussusception, but the current versions are not clearly linked. Due to a potential risk they are not recommended in babies who have had intussusception. The vaccines are made from weakened rotavirus.

The vaccine first became available in the United States in 2006. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between US$6.96 and $20.66 per dose as of 2014.In the United States it is more than US$200. As of 2013 there are two types of vaccine available globally, Rotarix and RotaTeq. Others are used in some countries.

The global market for Rotavirus Vaccines was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rotavirus Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Rotavirus Vaccines by region & country, by Type, and by Application.

The Rotavirus Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rotavirus Vaccines.

Market Segmentation

Scope of Rotavirus Vaccines - Market Report

Report Metric	Details
Report Name	Rotavirus Vaccines - Market
CAGR	5%
Segment by Type:	Rotarix RotaTeq Rotavac Rotavin-M1 Lanzhou lamb Others
Segment by Application	Adult Pediatric
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bharat Biotech, Merck & Co., Inc, GlaxoSmithKline plc, Lanzhou Institute of Biological, Bharat Biotech International Limited
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Rotavirus Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Rotavirus Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Rotavirus Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Rotavirus Vaccines - Market report?

Ans: The main players in the Rotavirus Vaccines - Market are Bharat Biotech, Merck & Co., Inc, GlaxoSmithKline plc, Lanzhou Institute of Biological, Bharat Biotech International Limited

What are the Application segmentation covered in the Rotavirus Vaccines - Market report?

Ans: The Applications covered in the Rotavirus Vaccines - Market report are Adult, Pediatric

What are the Type segmentation covered in the Rotavirus Vaccines - Market report?

Ans: The Types covered in the Rotavirus Vaccines - Market report are Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, Others

1 Market Overview

1.1 Rotavirus Vaccines Product Introduction

1.2 Global Rotavirus Vaccines Market Size Forecast

1.2.1 Global Rotavirus Vaccines Sales Value (2019-2030)

1.2.2 Global Rotavirus Vaccines Sales Volume (2019-2030)

1.2.3 Global Rotavirus Vaccines Sales Price (2019-2030)

1.3 Rotavirus Vaccines Market Trends & Drivers

1.3.1 Rotavirus Vaccines Industry Trends

1.3.2 Rotavirus Vaccines Market Drivers & Opportunity

1.3.3 Rotavirus Vaccines Market Challenges

1.3.4 Rotavirus Vaccines Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Rotavirus Vaccines Players Revenue Ranking (2023)

2.2 Global Rotavirus Vaccines Revenue by Company (2019-2024)

2.3 Global Rotavirus Vaccines Players Sales Volume Ranking (2023)

2.4 Global Rotavirus Vaccines Sales Volume by Company Players (2019-2024)

2.5 Global Rotavirus Vaccines Average Price by Company (2019-2024)

2.6 Key Manufacturers Rotavirus Vaccines Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Rotavirus Vaccines Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Rotavirus Vaccines

2.9 Rotavirus Vaccines Market Competitive Analysis

2.9.1 Rotavirus Vaccines Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Rotavirus Vaccines Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rotavirus Vaccines as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Rotarix

3.1.2 RotaTeq

3.1.3 Rotavac

3.1.4 Rotavin-M1

3.1.5 Lanzhou lamb

3.1.6 Others

3.2 Global Rotavirus Vaccines Sales Value by Type

3.2.1 Global Rotavirus Vaccines Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Rotavirus Vaccines Sales Value, by Type (2019-2030)

3.2.3 Global Rotavirus Vaccines Sales Value, by Type (%) (2019-2030)

3.3 Global Rotavirus Vaccines Sales Volume by Type

3.3.1 Global Rotavirus Vaccines Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Rotavirus Vaccines Sales Volume, by Type (2019-2030)

3.3.3 Global Rotavirus Vaccines Sales Volume, by Type (%) (2019-2030)

3.4 Global Rotavirus Vaccines Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Adult

4.1.2 Pediatric

4.2 Global Rotavirus Vaccines Sales Value by Application

4.2.1 Global Rotavirus Vaccines Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Rotavirus Vaccines Sales Value, by Application (2019-2030)

4.2.3 Global Rotavirus Vaccines Sales Value, by Application (%) (2019-2030)

4.3 Global Rotavirus Vaccines Sales Volume by Application

4.3.1 Global Rotavirus Vaccines Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Rotavirus Vaccines Sales Volume, by Application (2019-2030)

4.3.3 Global Rotavirus Vaccines Sales Volume, by Application (%) (2019-2030)

4.4 Global Rotavirus Vaccines Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Rotavirus Vaccines Sales Value by Region

5.1.1 Global Rotavirus Vaccines Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Rotavirus Vaccines Sales Value by Region (2019-2024)

5.1.3 Global Rotavirus Vaccines Sales Value by Region (2025-2030)

5.1.4 Global Rotavirus Vaccines Sales Value by Region (%), (2019-2030)

5.2 Global Rotavirus Vaccines Sales Volume by Region

5.2.1 Global Rotavirus Vaccines Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Rotavirus Vaccines Sales Volume by Region (2019-2024)

5.2.3 Global Rotavirus Vaccines Sales Volume by Region (2025-2030)

5.2.4 Global Rotavirus Vaccines Sales Volume by Region (%), (2019-2030)

5.3 Global Rotavirus Vaccines Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Rotavirus Vaccines Sales Value, 2019-2030

5.4.2 North America Rotavirus Vaccines Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Rotavirus Vaccines Sales Value, 2019-2030

5.5.2 Europe Rotavirus Vaccines Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Rotavirus Vaccines Sales Value, 2019-2030

5.6.2 Asia Pacific Rotavirus Vaccines Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Rotavirus Vaccines Sales Value, 2019-2030

5.7.2 South America Rotavirus Vaccines Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Rotavirus Vaccines Sales Value, 2019-2030

5.8.2 Middle East & Africa Rotavirus Vaccines Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Rotavirus Vaccines Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Rotavirus Vaccines Sales Value

6.2.1 Key Countries/Regions Rotavirus Vaccines Sales Value, 2019-2030

6.2.2 Key Countries/Regions Rotavirus Vaccines Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Rotavirus Vaccines Sales Value, 2019-2030

6.3.2 United States Rotavirus Vaccines Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Rotavirus Vaccines Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Rotavirus Vaccines Sales Value, 2019-2030

6.4.2 Europe Rotavirus Vaccines Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Rotavirus Vaccines Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Rotavirus Vaccines Sales Value, 2019-2030

6.5.2 China Rotavirus Vaccines Sales Value by Type (%), 2023 VS 2030

6.5.3 China Rotavirus Vaccines Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Rotavirus Vaccines Sales Value, 2019-2030

6.6.2 Japan Rotavirus Vaccines Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Rotavirus Vaccines Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Rotavirus Vaccines Sales Value, 2019-2030

6.7.2 South Korea Rotavirus Vaccines Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Rotavirus Vaccines Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Rotavirus Vaccines Sales Value, 2019-2030

6.8.2 Southeast Asia Rotavirus Vaccines Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Rotavirus Vaccines Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Rotavirus Vaccines Sales Value, 2019-2030

6.9.2 India Rotavirus Vaccines Sales Value by Type (%), 2023 VS 2030

6.9.3 India Rotavirus Vaccines Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Bharat Biotech

7.1.1 Bharat Biotech Company Information

7.1.2 Bharat Biotech Introduction and Business Overview

7.1.3 Bharat Biotech Rotavirus Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Bharat Biotech Rotavirus Vaccines Product Offerings

7.1.5 Bharat Biotech Recent Development

7.2 Merck & Co., Inc

7.2.1 Merck & Co., Inc Company Information

7.2.2 Merck & Co., Inc Introduction and Business Overview

7.2.3 Merck & Co., Inc Rotavirus Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Merck & Co., Inc Rotavirus Vaccines Product Offerings

7.2.5 Merck & Co., Inc Recent Development

7.3 GlaxoSmithKline plc

7.3.1 GlaxoSmithKline plc Company Information

7.3.2 GlaxoSmithKline plc Introduction and Business Overview

7.3.3 GlaxoSmithKline plc Rotavirus Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.3.4 GlaxoSmithKline plc Rotavirus Vaccines Product Offerings

7.3.5 GlaxoSmithKline plc Recent Development

7.4 Lanzhou Institute of Biological

7.4.1 Lanzhou Institute of Biological Company Information

7.4.2 Lanzhou Institute of Biological Introduction and Business Overview

7.4.3 Lanzhou Institute of Biological Rotavirus Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Lanzhou Institute of Biological Rotavirus Vaccines Product Offerings

7.4.5 Lanzhou Institute of Biological Recent Development

7.5 Bharat Biotech International Limited

7.5.1 Bharat Biotech International Limited Company Information

7.5.2 Bharat Biotech International Limited Introduction and Business Overview

7.5.3 Bharat Biotech International Limited Rotavirus Vaccines Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Bharat Biotech International Limited Rotavirus Vaccines Product Offerings

7.5.5 Bharat Biotech International Limited Recent Development

8 Industry Chain Analysis

8.1 Rotavirus Vaccines Industrial Chain

8.2 Rotavirus Vaccines Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Rotavirus Vaccines Sales Model

8.5.2 Sales Channel

8.5.3 Rotavirus Vaccines Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Bharat Biotech

Merck& Co. Inc

GlaxoSmithKline PLC

Lanzhou Institute of Biological

Bharat Biotech International Limited

List of Tables

Table 1. Rotavirus Vaccines Market Trends

Table 2. Rotavirus Vaccines Market Drivers & Opportunity

Table 3. Rotavirus Vaccines Market Challenges

Table 4. Rotavirus Vaccines Market Restraints

Table 5. Global Rotavirus Vaccines Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Rotavirus Vaccines Revenue Market Share by Company (2019-2024)

Table 7. Global Rotavirus Vaccines Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Rotavirus Vaccines Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Rotavirus Vaccines Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Rotavirus Vaccines Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Rotavirus Vaccines Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Rotavirus Vaccines

Table 13. Global Rotavirus Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rotavirus Vaccines as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Rotavirus Vaccines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Rotavirus Vaccines Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Rotavirus Vaccines Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Rotavirus Vaccines Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Rotavirus Vaccines Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Rotavirus Vaccines Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Rotavirus Vaccines Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Rotavirus Vaccines Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Rotavirus Vaccines Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Rotavirus Vaccines Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Rotavirus Vaccines Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Rotavirus Vaccines Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Rotavirus Vaccines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Rotavirus Vaccines Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Rotavirus Vaccines Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Rotavirus Vaccines Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Rotavirus Vaccines Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Rotavirus Vaccines Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Rotavirus Vaccines Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Rotavirus Vaccines Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Rotavirus Vaccines Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Rotavirus Vaccines Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Rotavirus Vaccines Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Rotavirus Vaccines Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Rotavirus Vaccines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Rotavirus Vaccines Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Rotavirus Vaccines Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Rotavirus Vaccines Sales Value by Region (2019-2024) & (%)

Table 44. Global Rotavirus Vaccines Sales Value by Region (2025-2030) & (%)

Table 45. Global Rotavirus Vaccines Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Rotavirus Vaccines Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Rotavirus Vaccines Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Rotavirus Vaccines Sales Volume by Region (2019-2024) & (%)

Table 49. Global Rotavirus Vaccines Sales Volume by Region (2025-2030) & (%)

Table 50. Global Rotavirus Vaccines Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Rotavirus Vaccines Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Rotavirus Vaccines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Rotavirus Vaccines Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Rotavirus Vaccines Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Rotavirus Vaccines Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Rotavirus Vaccines Sales Volume, (2025-2030) & (K Units)

Table 57. Bharat Biotech Company Information

Table 58. Bharat Biotech Introduction and Business Overview

Table 59. Bharat Biotech Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Bharat Biotech Rotavirus Vaccines Product Offerings

Table 61. Bharat Biotech Recent Development

Table 62. Merck & Co., Inc Company Information

Table 63. Merck & Co., Inc Introduction and Business Overview

Table 64. Merck & Co., Inc Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. Merck & Co., Inc Rotavirus Vaccines Product Offerings

Table 66. Merck & Co., Inc Recent Development

Table 67. GlaxoSmithKline plc Company Information

Table 68. GlaxoSmithKline plc Introduction and Business Overview

Table 69. GlaxoSmithKline plc Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. GlaxoSmithKline plc Rotavirus Vaccines Product Offerings

Table 71. GlaxoSmithKline plc Recent Development

Table 72. Lanzhou Institute of Biological Company Information

Table 73. Lanzhou Institute of Biological Introduction and Business Overview

Table 74. Lanzhou Institute of Biological Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Lanzhou Institute of Biological Rotavirus Vaccines Product Offerings

Table 76. Lanzhou Institute of Biological Recent Development

Table 77. Bharat Biotech International Limited Company Information

Table 78. Bharat Biotech International Limited Introduction and Business Overview

Table 79. Bharat Biotech International Limited Rotavirus Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Bharat Biotech International Limited Rotavirus Vaccines Product Offerings

Table 81. Bharat Biotech International Limited Recent Development

Table 82. Key Raw Materials Lists

Table 83. Raw Materials Key Suppliers Lists

Table 84. Rotavirus Vaccines Downstream Customers

Table 85. Rotavirus Vaccines Distributors List

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

List of Figures

Figure 1. Rotavirus Vaccines Product Picture

Figure 2. Global Rotavirus Vaccines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Rotavirus Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Rotavirus Vaccines Sales Volume (2019-2030) & (K Units)

Figure 5. Global Rotavirus Vaccines Sales Price (2019-2030) & (USD/Unit)

Figure 6. Rotavirus Vaccines Report Years Considered

Figure 7. Global Rotavirus Vaccines Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Rotavirus Vaccines Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Rotavirus Vaccines Revenue in 2023

Figure 10. Rotavirus Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Rotarix Picture

Figure 12. RotaTeq Picture

Figure 13. Rotavac Picture

Figure 14. Rotavin-M1 Picture

Figure 15. Lanzhou lamb Picture

Figure 16. Others Picture

Figure 17. Global Rotavirus Vaccines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 18. Global Rotavirus Vaccines Sales Value Market Share by Type, 2023 & 2030

Figure 19. Global Rotavirus Vaccines Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 20. Global Rotavirus Vaccines Sales Volume Market Share by Type, 2023 & 2030

Figure 21. Global Rotavirus Vaccines Price by Type (2019-2030) & (USD/Unit)

Figure 22. Product Picture of Adult

Figure 23. Product Picture of Pediatric

Figure 24. Global Rotavirus Vaccines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 25. Global Rotavirus Vaccines Sales Value Market Share by Application, 2023 & 2030

Figure 26. Global Rotavirus Vaccines Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 27. Global Rotavirus Vaccines Sales Volume Market Share by Application, 2023 & 2030

Figure 28. Global Rotavirus Vaccines Price by Application (2019-2030) & (USD/Unit)

Figure 29. North America Rotavirus Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 30. North America Rotavirus Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 31. Europe Rotavirus Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 32. Europe Rotavirus Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 33. Asia Pacific Rotavirus Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Rotavirus Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 35. South America Rotavirus Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 36. South America Rotavirus Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 37. Middle East & Africa Rotavirus Vaccines Sales Value (2019-2030) & (US$ Million)

Figure 38. Middle East & Africa Rotavirus Vaccines Sales Value by Country (%), 2023 VS 2030

Figure 39. Key Countries/Regions Rotavirus Vaccines Sales Value (%), (2019-2030)

Figure 40. Key Countries/Regions Rotavirus Vaccines Sales Volume (%), (2019-2030)

Figure 41. United States Rotavirus Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 42. United States Rotavirus Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 43. United States Rotavirus Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 44. Europe Rotavirus Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 45. Europe Rotavirus Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 46. Europe Rotavirus Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 47. China Rotavirus Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 48. China Rotavirus Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 49. China Rotavirus Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 50. Japan Rotavirus Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 51. Japan Rotavirus Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 52. Japan Rotavirus Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 53. South Korea Rotavirus Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 54. South Korea Rotavirus Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 55. South Korea Rotavirus Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 56. Southeast Asia Rotavirus Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 57. Southeast Asia Rotavirus Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 58. Southeast Asia Rotavirus Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 59. India Rotavirus Vaccines Sales Value, (2019-2030) & (US$ Million)

Figure 60. India Rotavirus Vaccines Sales Value by Type (%), 2023 VS 2030

Figure 61. India Rotavirus Vaccines Sales Value by Application (%), 2023 VS 2030

Figure 62. Rotavirus Vaccines Industrial Chain

Figure 63. Rotavirus Vaccines Manufacturing Cost Structure

Figure 64. Channels of Distribution (Direct Sales, and Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions